key: cord-0859297-chrnaogz authors: Potla, Neha; Veluri, Savithri-Chandana; Stead, Thor S; Dubey, Jesse; Ganti, Latha title: Pelvic Congestion Syndrome in a Postmenopausal Female date: 2021-08-25 journal: Cureus DOI: 10.7759/cureus.17444 sha: eb740ce535793dcba396a167ce76490164b7a12d doc_id: 859297 cord_uid: chrnaogz This study reports the case of a 53-year-old postmenopausal woman and explores her unique experience with pelvic congestion syndrome (PCS). PCS is a relatively newly recognized entity and is still a diagnosis of exclusion. We analyze the presenting symptoms and imaging findings on CT and ultrasonography. We also examine the potential causes of this ambiguous prognosis. This case is unusual in that PCS usually presents in premenopausal rather than postmenopausal women. The scope of current knowledge on pelvic congestion syndrome (PCS) is sparse as it is a relatively newly recognized entity and a diagnosis of exclusion. PCS is a chronic condition that commonly affects females of childbearing age, especially women who have given birth to multiple children. It results in aching or sharp bursts of pelvic pain [1] . Although the syndrome is relatively new, the prevalence of the disease in women is nearly 30% as PCS is frequently misdiagnosed [2] . The cause of the congestion has yet to be elucidated; however, the etiology appears to be multifactorial. Currently, three speculations exist on its etiology: 1) valvular insufficiency of ovarian vein or internal iliac veins leading to stasis of blood, 2) venous outflow obstruction due to extrinsic compression of pelvic veins, and 3) vasodilatory effect of estrogen on pelvic vasculature. This case presentation challenges the third speculation. The condition is rarely seen in postmenopausal women because estrogen levels are lower in this age group. The main symptoms of PCS are abdominal pain on the left side more than the right that lasts for at least six months. Pain is typically exacerbated by factors that increase intra-abdominal pressure, such as prolonged standing, and is relieved by lying down. Pain worsens during menstrual periods, before and after coitus, and during pregnancy. PCS is associated with irritable bowel symptoms and stress incontinence. Left-sided pain is more common, perhaps due to a higher incidence of congenital absence of valves of the left ovarian vein. The left ovarian vein drains into the renal vein in contrast with the right ovarian vein that drains directly into the inferior vena cava. The pain is typically dull and exacerbated by general movement. There is often accompanying increased urinary frequency, abnormal menstruation, irritable bowel symptoms, and enlarged veins around the vulva area and pelvic floor [3] . The treatment options for PCS are embolization, gonadotropin-releasing hormone drugs to block ovarian function, progestin hormone drugs to relieve pain, and hysterectomy. Pelvic floor physical therapy is an adjunctive treatment that may help with coexisting pelvic floor dysfunction and abnormal bowel and bladder function. Behavioral therapy for associated conditions such as depression, anxiety, and sexual dysfunction can also be considered. PCS is a diagnosis of exclusion [4] . A 53-year-old postmenopausal female presented with severe abdominal pain and bloating in the suprapubic area. The pain had started three days prior and was worse on the left side. Her surgical history was significant only for a cholecystectomy. Her only daily prescription was duloxetine 30 mg daily for the past year for anxiety related to coronavirus disease 2019 (COVID-19). She reported that the pain worsened when engaged in daily activities such as walking, a key symptom of PCS. She denied fevers, chills, chest pains, shortness of breath, nausea, vomiting, diarrhea, or constipation. Her vital signs included a blood pressure of 108/67 mmHg, temperature of 98.7 °F, pulse rate of 98 beats per minute, respiratory rate of 16 breaths per minute, and oxygen saturation of 99% on room air. Her physical exam was only remarkable for left-sided abdominal pain. Her laboratory analysis was unremarkable except for slight traces of blood and ketones in the urine ( Table 1 ). The patient was given intravenous ketorolac for analgesia, and she experienced relief. She was tentatively diagnosed with PCS based on the exquisite pain dominant on the left, increased pain when performing daily activities, and the findings of enlarged pelvic veins on imaging. She was discharged home with a follow-up arrangement in a clinic that specializes in treating PCS. This particular case of PCS is unique as instances of postmenopausal females reporting pelvic congestion syndrome are sporadic at best. Women in menopause have less estrogen because the ovaries decrease their rate of production. Estrogen dilates the veins. During menopause, when estrogen levels are low, the pelvis's blood supply decreases [5] . This is why vein fluid build-up is unlikely; however, for postmenopausal females, it is still possible to acquire PCS if the veins have been severely dilated. The abnormality of our patient's case centered on her particular symptoms. She reported normal bowel movements, no dysuria, and no bulging veins around the thighs or vulva. Approximately 65-79% of women with PCS report irritable bowel syndrome (IBS) [6] , but our patient did not. Similarly, patients with PCS often report urological symptoms like dysuria or painful urination, hematuria, and polyuria [1] , and again our patient did not. She experienced no additional pain at the pelvic girdle or sacrum. There are several options to treat PCS. The first option involves hormonal medication that can significantly reduce the blood flow to the veins and eventually minimize the prevalence of the varicose veins. The medication is either gonadotropin-releasing hormone, which blocks the function of the ovaries to relieve pain, or synthetic progestin hormone, which activates progesterone receptors to relieve pain. This option is the least invasive; however, if medication proves to be ineffective, there are minimally invasive procedures to alleviate the pain. The second option is nonsurgical embolization or sclerotherapy, which intentionally shuts off damaged veins and prevents further build-up. For the embolization, a catheter is inserted into a vein in the upper arm, shoulder, or thigh depending on the area of the problem and follows the vein to the source of the pain through radiographic guidance. Finally, the third procedural option is to surgically remove the damaged vein(s) or to have a hysterectomy [7] . Generally, the least invasive methods are attempted first (Figure 4 ). There are two case reports of postmenopausal women experiencing PCS in the literature so far. Neither of those cases is similar to our patient's experience. The first one was in a 55-year-old woman with congenital varicosities [8] . The second one was in a 69-year-old postmenopausal patient with varicose veins, but she was asymptomatic. The lack of symptoms is very uncharacteristic of PCS [9] . Furthermore, other syndromes like May-Thurner appear to have similarities with PCS, which seem to be more applicable to patients experiencing menopause. One interesting aspect to note in our patient's case is the implantable birth control device noted on ultrasound. This is a permanently implanted metal birth control coil that was recalled in September of 2019 [10] . Another patient had presented with a dull lower abdominal pain after the insertion of this device. The blood urine in postmenopausal women needs to be further worked up. This issue led to the speculation of a complication arising from a urinary tract infection (UTI). This patient also explained that over time the pain had become constant and exacerbated during intercourse. The pelvic pain continued to worsen until she requested to have the device removed through a laparoscopic bilateral total salpingectomy. After removal, the patient conclusively reported that the chronic pelvic pain resolved itself [11] . It is possible that her pain was related to this device as well. It is likely that this device may have caused external compression of ovarian veins. It is also possible that the patient may have genetic factors like absent valves of ovarian veins that predisposed her to PCS. Patients with implantable birth control devices like the one our patient had are also known to have reported increased incidence of abnormal uterine bleeding as a common side effect, implying that in spite of menopause, the device could have caused a state of 'hormonal dysfunction' with relatively higher estrogen than progesterone, thereby increasing the risk of PCS. Indeed, many women have previously reported pelvic pain after being implanted with this device and litigated [12] . One other plausible diagnosis is May-Thurner syndrome (MTS), which occurs when the left iliac vein is compressed by its right iliac counterpart. This can increase the risk of deep vein thrombosis (DVT) or blood clot that causes pain on a slightly left trajectory. MTS is also less common in older females [13] . MTS can often be mistaken for PCS [14] . Both syndromes share areas of pain in the pelvic region. This case highlights the importance of obtaining a thorough history from the patient, and keeping a broad differential, even when symptoms are atypical or present in an atypical patient. PCS is a condition that can lead to significant morbidity due to the chronic, often disabling nature of the pain it causes. It is most commonly seen in premenopausal women. PCS is rarely reported in postmenopausal women, but it does occur, as discussed in this case report. . Based on the information provided and attested is true, the research plan described does not require IRB oversight. This is because the investigators are either a) not engaging in research with human subjects as defined by federal regulations; b) engaging in research with human subjects deemed excluded from IRB oversight per 45CFR46.102(l) OR c) engaging in research with sufficient human subject protections in the design to meet one or more IRB exemption criteria set forth in 45CFR46.104. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. A forgotten disease: pelvic congestion syndrome as a cause of chronic lower abdominal pain Diagnosis and treatment of the pelvic congestion syndrome Pelvic congestion syndrome: the current state of the literature Progesterone effects on varicose veins Options for pelvic congestion syndrome Pelvic congestion syndrome: prevalence and quality of life An unusual cause of postmenopausal vaginal haemorrhage: a case report Pelvic congestion syndrome (PCS) as a pathology of postmenopausal women: a case report with literature review Essure permanent birth control devices/implants-and-prosthetics/essure-permanent-birth-control Essure surgical removal and subsequent resolution of chronic pelvic pain: a case report and review of the literature Essure® and chronic pelvic pain: a population-based cohort May-Thurner syndrome presenting as pelvic congestion syndrome and vulvar varicosities in a nonpregnant adolescent This research was supported (in whole or in part) by HCA Healthcare and/or an HCA Healthcare-affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities.